HyLabs is a company that provides products and services in the fields of microorganisms and molecular biology. The company's core business includes advanced genetic testing for cancer patients through its acquired company Progenetics, which offers a wide range of oncology tests in Israel. HyLabs also provides services to various markets, including healthcare, industrial, environmental, and academic research, with a focus on quality, reliability, and exceptional service. The company holds various certifications and accreditations, such as ISO 9001:2015, ISO 13485:2016, and ISO/IEC 17025:2017, and is registered with the FDA, demonstrating its commitment to meeting regulatory requirements and delivering high-quality products and services.

Founded in 1974, hylabs is the market leader in developing, manufacturing and marketing of diagnostic tests. hylabs provides a full range of products and services to the healthcare, industrial, environmental and research markets. Our proven product quality, reliability, highly experienced R&D staff, combined with a strict QC, have set the industry standard for more than 40 years.

• Hy-Giene Monitor system (HGM) - double-sided agar slide.
Among HGM is our new and unique product:
Hy-Resistance - environmental monitor for detecting of resistant bacteria in hospitals (such as Acinetobacter on MDR/mSuperCARBA).
• Prepared Culture Media (Plates, Test Tubes & Bottles)
• Irradiated Contact& Settling plates
• Hy-Enterotest – detection of 27 bacteria in 1 tube.
• qPCR kits for detection of infectious diseases. Including multiplex qPCR CRE kit (Carbapenem-Resistant Enterobacter)
• Oligo production
• Buffers (PBS, TAE, SDS and customized)

1974